Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Implants / Devices
    • Philips to ramp up...

    Philips to ramp up production of ventilators in coronavirus fight

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 28 March 2020 7:30 AM  |  Updated On 28 March 2020 7:31 AM
    Philips to ramp up production of ventilators in coronavirus fight

    Amsterdam: Dutch health technology company Philips is to ramp up production of critical healthcare products to help diagnose and treat patients with the new coronavirus disease COVID-19.

    Philips said on Sunday that it aimed to double its production of hospital ventilators within the next eight weeks and to achieve a four-fold increase by the third quarter.

    "We currently make around a thousand ventilators per week and are looking to reach around 2,000 in the coming weeks," Chief Executive Frans van Houten told Reuters.

    "We will continue to increase production because we see an enormous demand."

    Van Houten said he had been in contact with his main competitors, such as Draeger (DRWG.DE) and Medtronic (MDT.N), who he said was also aiming to increase production.

    "Our increase alone will certainly not be enough," he said. "But together, we hope to come towards meeting demand."

    Van Houten said Philips also hopes to increase the production of other equipment critical in the fight against COVID-19, such as vital signs monitors, diagnostic imaging systems and software solutions for hospitals to monitor and manage patients in intensive care units.

    For this, Philips expects to hire extra manufacturing staff as well as shifting current staff to the production lines where they are most needed.

    "But the most important part is to get suppliers to cooperate, to facilitate the ramp-up in production", Van Houten said.

    Read also: Philips, European Society of Radiology to host Ultrasound Academy at ECR 2020

    Despite the increased demand for its critical healthcare equipment, Philips said it expected the coronavirus outbreak to harm its results in the first half of 2020.

    Philips had earlier already warned about the impact of the pandemic on first-quarter earnings because the demand for its consumer products has waned and global supply chains have been severely disrupted.

    Read also: Philips announces DEFINE GPS global multicenter study to assess outcomes of PCI procedures guided by integrated iFR and interventional X-ray images

    philipscoronaviruscovid-19ventilator
    Source : Reuters

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok